文献速递精神分裂症与精神病性障碍儿童青少年精神老年精神

表观遗传分析提示老年孤独症谱系障碍与精神分裂症患者小脑脑龄异常

Epigenetic analysis suggests aberrant cerebellum brain aging in old-aged adults with autism spectrum disorder and schizophrenia.
PubMed 文献 · Mol Psychiatry · 2023-08-24

该研究基于两个死后脑组织全基因组DNA甲基化数据集(孤独症谱系障碍222例,精神分裂症142例),采用Horvath表观遗传时钟评估脑衰老。结果显示DNAm年龄与实际年龄在多个脑区强相关;45岁以上孤独症谱系障碍患者小脑表观遗传年龄加速大于对照,50-70岁精神分裂症患者小脑表观遗传衰老减缓;但总样本和性别亚组中未见显著差异。

要点

  • 45岁以上孤独症谱系障碍患者小脑表观遗传年龄加速显著大于对照。
  • 50-70岁精神分裂症患者小脑表观遗传衰老显著减缓。
  • 总样本及性别亚组中孤独症谱系障碍和精神分裂症与对照无显著差异。

核心结论

  • 研究提示老年孤独症谱系障碍和精神分裂症患者存在小脑表观遗传脑衰老异常,且两种疾病小脑衰老模式不同。

研究设计与样本

  • 基于两个公开的死后脑组织全基因组DNA甲基化数据集,孤独症谱系障碍样本222例,精神分裂症样本142例,使用Horvath表观遗传时钟计算表观遗传年龄加速。
  • 样本按性别和年龄分为亚组,比较各组间表观遗传年龄加速的差异。

主要发现

  • 两个数据集中DNAm年龄与实际年龄在多个脑区强相关(P < 0.05)。
  • 45岁以上孤独症谱系障碍患者小脑表观遗传年龄加速为5.069,对照为-6.249,差异显著(P < 0.001)。
  • 50-70岁精神分裂症患者小脑表观遗传年龄加速为-3.171,对照为2.418,差异显著(P < 0.05)。
  • 总样本和性别特异性组中,孤独症谱系障碍与对照、精神分裂症与对照的表观遗传年龄加速均无显著差异(P > 0.05)。

临床怎么用

  • 提示对老年孤独症谱系障碍和精神分裂症患者需关注小脑相关功能,表观遗传时钟或可辅助评估脑衰老模式。
  • 研究结果尚需更大样本队列验证,暂不宜作为临床常规检测依据。

局限性

  • 研究使用死后脑组织样本,样本来源和数量有限,结论需更大规模孤独症谱系障碍和精神分裂症队列进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aberrant aging hypothesis of schizophrenia (SCZ) and autism spectrum disorder (ASD) has been proposed, and the DNA methylation (DNAm) clock, which is a cumulative evaluation of DNAm levels at age-related CpGs, could serve as a biological aging indicator. This study evaluated epigenetic brain aging of ASD and SCZ using Horvath's epigenetic clock, based on two public genome-wide DNA methylation datasets of post-mortem brain samples (NASD = 222; NSCZ = 142). Total subjects were further divided into subgroups by gender and age. The epigenetic age acceleration (AgeAccel) for each sample was calculated as the residual value resulting from the regression model and compared between groups. Results showed DNAm age has a strong correlation with chronological age in both datasets across multiple brain regions (P < 0.05). When divided into equally sized age groups, the AgeAccel of the cerebellum (CB) region from people over 45 years of age was greater compared to the control sample (AgeAccel of ASD vs control: 5.069 vs -6.249; P < 0.001). And a decelerated epigenetic aging process was observed in the CB region of individuals with SCZ aged 50-70 years (AgeAccel of SCZ vs control: -3.171 vs 2.418; P < 0.05). However, our results showed no significant difference in AgeAccel between ASD and control groups, and between SCZ and control groups in the total and gender-specific groups (P > 0.05). This study's results revealed some evidence for aberrant epigenetic CB brain aging in old-aged patients with ASD and SCZ, indicating a different pattern of CB aging in older adults with these two diseases. However, further studies of larger ASD and SCZ cohorts are necessary to make definitive conclusions on this observation.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liu L, Qi X, Cheng S, et al. Epigenetic analysis suggests aberrant cerebellum brain aging in old-aged adults with autism spectrum disorder and schizophrenia. Mol Psychiatry. 2023. PMID: 37612365. doi:10.1038/s41380-023-02233-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。